Telehealth & Digital Health

Co-Diagnostics leverages its COVID-19 success for a strategic push into Latin America, aiming to bring rapid PCR testing for a host of diseases to Mexico.

For millions, the 'why' behind infertility remains a mystery. New genomic mapping tech is finally providing answers, changing the landscape of family planning.

As Canada ages, one annual pitch contest reveals its true intent: not just to award ideas, but to strategically build a national AgeTech ecosystem.

In a bold strategic move, ivari is bundling on-demand healthcare with life insurance, signaling a market shift from passive protection to proactive wellness.

Major academic centers no longer hold a monopoly on medical breakthroughs. A look at how community networks are democratizing cutting-edge cancer research.

Sun Life's Jacques Goulet brings a background in risk management and a proven record of philanthropic impact to his new role as Chair of the MHIF.

Nancy Torres analyzes Héma-Québec's summer tour, revealing a sophisticated strategy to combat supply chain risks, secure plasma independence, and diversify its donor base.

Hainan's new medical tourism hub is more than a hospital—it's a strategic play for global dominance, using exclusive drugs and VIP service to lure patients.

Aethlon Medical is advancing a device to filter pathogens from the bloodstream, viewing it as a firewall for the body's internal communication network.

A new partnership between health tech pioneer Snke and biotech firm Precision NeuroMed aims to build a data-driven roadmap for treating neurological diseases.

In a region hit hard by lung cancer, Tanner Health proves innovation isn't just for big cities, deploying a powerful AI to save lives in Georgia and Alabama.

A new partnership between Daybreak and VHSS isn't just about a new device; it’s a durable model for delivering resilient healthcare solutions to veterans.

A new app, born from its founder's personal health battle, challenges the 'no pain, no gain' ethos of digital wellness with a flexible, empathetic model.

Dissecting the Med-Metrix acquisition of CanAide. A strategic move by private equity to capture the booming RCM market by tackling provider costs and patient access.

Beacon Biosignals is merging AI-driven brain monitoring with home sleep testing, creating a powerful new platform that could redefine neurological diagnostics.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

A new Florida venture embeds sleep apnea treatment into cardiology care, a model that could reshape patient outcomes and Vivos Therapeutics' market strategy.

Replacing a controversial task force, Canada's new NACPHS aims to modernize health guidelines with a focus on equity, patient input, and scientific agility.

NBA legend Shaquille O'Neal's campaign for Zepbound spotlights a silent health epidemic, but the drug's high cost and the ethics of celebrity ads loom large.

Soaring healthcare costs, fueled by GLP-1 drugs, have employers trapped. A new report shows why flexible benefits are becoming a critical survival strategy.